GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Effective Interest Rate on Debt %

Kindstar Globalgene Technology (HKSE:09960) Effective Interest Rate on Debt % : 3.35% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Kindstar Globalgene Technology's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was HK$13.7 Mil. Kindstar Globalgene Technology's average total debt for the quarter that ended in Dec. 2024 was HK$408.6 Mil. Therefore, Kindstar Globalgene Technology's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 3.35%.

Kindstar Globalgene Technology Effective Interest Rate on Debt % Historical Data

The historical data trend for Kindstar Globalgene Technology's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Effective Interest Rate on Debt % Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 1.24 3.59 2.29 4.03 3.71

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 2.95 4.45 3.33 3.35

Competitive Comparison of Kindstar Globalgene Technology's Effective Interest Rate on Debt %

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindstar Globalgene Technology's Effective Interest Rate on Debt % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Effective Interest Rate on Debt % falls into.


;
;

Kindstar Globalgene Technology Effective Interest Rate on Debt % Calculation

Kindstar Globalgene Technology's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  -11.838/( (212.509+425.32)/ 2 )
=-1  *  -11.838/318.9145
=3.71 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=32 + 180.509
=212.509

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=100.381 + 324.939
=425.32

Kindstar Globalgene Technology's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2024 )+Total Debt  (Q: Dec. 2024 ))/ count )
=-1  *  -13.686/( (391.788+425.32)/ 2 )
=-1  *  -13.686/408.554
=3.35 %

where

Total Debt  (Q: Jun. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=105.97 + 285.818
=391.788

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=100.381 + 324.939
=425.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Kindstar Globalgene Technology  (HKSE:09960) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Kindstar Globalgene Technology Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Effective Interest Rate on Debt %
Comparable Companies
HKSE:06667 HKSE:02325 HKSE:08037 HKSE:02427 HKSE:08225 HKSE:08247 HKSE:00928 HKSE:09860 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH
Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Website
https://www.kindstar.com.cn
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Executives
Orbimed Asia Partners Iv, L.p. 2101 Beneficial owner
Orbimed Asia Gp Iv, L.p. 2201 Interest of corporation controlled by you
Orbimed Advisors Iv Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited 2101 Beneficial owner
Jackson Hole Trust Company
Huang Bo
Huang Shiang 2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Huang Zuie-chin 2101 Beneficial owner
Tu Zanbing
Kastle Limited 2301 Trustee

Kindstar Globalgene Technology Headlines

No Headlines